Sichuan Kelun-biotech Biopharmaceutical Co., Ltd.

This study tested an oral drug called KL130008 in 114 adults with severe alopecia areata, a condition causing significant scalp hair loss. The goal was to see if the drug could regrow hair to at least 80% coverage. However, the trial was terminated early, so the full results are …

This phase 3 trial tested a drug called A140 (similar to cetuximab) combined with chemotherapy (mFOLFOX6) as a first treatment for people with a specific type of advanced colorectal cancer (RAS wild-type). The study planned to enroll 570 people in China but was terminated early w…